Elle Pope

438 total citations
15 papers, 257 citations indexed

About

Elle Pope is a scholar working on Economics and Econometrics, Epidemiology and Pharmacology. According to data from OpenAlex, Elle Pope has authored 15 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 4 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Elle Pope's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (6 papers) and Pharmaceutical industry and healthcare (4 papers). Elle Pope is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (6 papers) and Pharmaceutical industry and healthcare (4 papers). Elle Pope collaborates with scholars based in United States and China. Elle Pope's co-authors include Peter J. Neumann, James D. Chambers, David D. Kim, Joshua T. Cohen, Fang Liz Zhou, Pei‐Jung Lin, Jennifer S. Graff, Neil Jay Sehgal, Dahai Yue and Dylan H. Roby and has published in prestigious journals such as Journal of General Internal Medicine, Health Affairs and BMJ Open.

In The Last Decade

Elle Pope

14 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elle Pope United States	7	97	74	43	38	25	15	257
Melanie Powis Canada	10	59 0.6×	33 0.4×	50 1.2×	41 1.1×	25 1.0×	47	343
Laure Delbecque United States	8	22 0.2×	111 1.5×	44 1.0×	62 1.6×	30 1.2×	29	258
Qi Cao Netherlands	11	96 1.0×	94 1.3×	31 0.7×	15 0.4×	12 0.5×	26	345
Štefan Varga United States	9	85 0.9×	65 0.9×	39 0.9×	15 0.4×	23 0.9×	27	266
Jamie Elvidge United Kingdom	11	86 0.9×	34 0.5×	38 0.9×	7 0.2×	20 0.8×	25	252
Tina K. Reddy United States	6	29 0.3×	35 0.5×	27 0.6×	13 0.3×	54 2.2×	13	303
Ahmad Faramarzi Iran	9	62 0.6×	25 0.3×	61 1.4×	35 0.9×	16 0.6×	20	249
Cuc Thi Thu Nguyen Vietnam	11	15 0.2×	80 1.1×	58 1.3×	20 0.5×	23 0.9×	37	323
Jay Visaria United States	10	89 0.9×	22 0.3×	18 0.4×	10 0.3×	23 0.9×	23	291
Shahrul Aiman Soelar Malaysia	11	12 0.1×	40 0.5×	20 0.5×	42 1.1×	51 2.0×	28	314

Countries citing papers authored by Elle Pope

Since Specialization

Citations

This map shows the geographic impact of Elle Pope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elle Pope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elle Pope more than expected).

Fields of papers citing papers by Elle Pope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elle Pope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elle Pope. The network helps show where Elle Pope may publish in the future.

Co-authorship network of co-authors of Elle Pope

This figure shows the co-authorship network connecting the top 25 collaborators of Elle Pope. A scholar is included among the top collaborators of Elle Pope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elle Pope. Elle Pope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Pope, Elle, et al.. (2025). Knowledge and attitudes regarding substance use disorder treatment and harm reduction practices among US pharmacists: A scoping review. Journal of the American Pharmacists Association. 65(5). 102462–102462. 1 indexed citations

Pope, Elle, et al.. (2024). Knowledge, practice and attitudes regarding substance use disorder treatment and harm reduction strategies among pharmacists: a scoping review protocol. BMJ Open. 14(2). e080338–e080338. 2 indexed citations

Pope, Elle & Neil Jay Sehgal. (2023). Characterizing industry payments to US teaching hospitals and affiliated physicians: a cross-sectional analysis of the Open Payments datasets from 2016 to 2022. Health Affairs Scholar. 1(2). qxad031–qxad031.

Pope, Elle & Neil Jay Sehgal. (2022). Effects and Trends in Opioid-Related Promotional Payments Between 2014 and 2019: a Panel Data Analysis Among Prescribers in Medicare Part D. Journal of General Internal Medicine. 37(13). 3509–3511. 1 indexed citations

Pope, Elle & Neil Jay Sehgal. (2022). The Role of Physician Networks and Receipt of Opioid-Related Payments. Journal of General Internal Medicine. 38(8). 1812–1820. 3 indexed citations

Sehgal, Neil Jay, et al.. (2022). The Association Between COVID-19 Mortality And The County-Level Partisan Divide In The United States. Health Affairs. 41(6). 853–863. 28 indexed citations

Chambers, James D., et al.. (2019). Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage. Health Affairs. 38(11). 1882–1886. 14 indexed citations

Chambers, James D., et al.. (2018). Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies. Journal of Managed Care & Specialty Pharmacy. 24(12). 1240–1246. 6 indexed citations

Anderson, J. Edgar, et al.. (2018). The Growth of Cost-Effectiveness Analyses in Asia. Value in Health. 21. S56–S56. 1 indexed citations

10.

Anderson, J. Edgar, et al.. (2018). Comparing Cost-Per-Qalys Gained And Cost-Per-Dalys Averted Analyses. Value in Health. 21. S118–S118. 3 indexed citations

11.

Chambers, James D., et al.. (2018). Specialty Drug Coverage Varies Across Commercial Health Plans In The US. Health Affairs. 37(7). 1041–1047. 44 indexed citations

12.

Lin, Pei‐Jung, Elle Pope, & Fang Liz Zhou. (2018). Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis. Diabetes Therapy. 9(5). 1907–1918. 31 indexed citations

13.

Olchanski, Natalia, Ryan N. Hansen, Elle Pope, et al.. (2018). Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value. Open Forum Infectious Diseases. 5(3). ofy031–ofy031. 54 indexed citations

14.

Chambers, James D., et al.. (2017). A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures. Value in Health. 21(4). 400–406. 3 indexed citations

15.

Kim, David D., et al.. (2017). The influence of time horizon on results of cost-effectiveness analyses. Expert Review of Pharmacoeconomics & Outcomes Research. 17(6). 615–623. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact